| <img alt="" height="1" width="1" />Ironwood Pharmaceuticals, Imperial Capital Test the IPO WatersSeeking Alpha (blog)Linaclotide was developed for those who suffer from irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC), two ailments that ...Ironwood Seeks 15% IPO Premium as Investors Lose in New Deals<nobr>BusinessWeek</nobr>IPO On Tap, Ironwood Aims for Big Pharma<nobr>Minyanville.com</nobr>Ironwood Gears Up for Biotech's Biggest IPO in Years, Sending Ripple Effect ...<nobr>Xconomy</nobr><nobr>Seeking Alpha (blog)</nobr><nobr>all 12 news articles »</nobr> |
Google- Ironwood Pharmaceuticals, Imperial Capital Test the IPO Waters - Seeking Alpha (blog)
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Join the discussion
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Recommended Communities
Join now to ask and comment!